Search Clinical Trials
By Condition
By Location (USA)
By Location (Other)
By Sponsor
Resources
Privacy Policy
About Us
Disclaimer
Buprenorphine Dosing Interval - 5 Clinical Trials References presented on Clinical Trials Search is not intended to be a substitute for proven healthcare advice, trips or professional assistance by using a real medical. We aren't mDs. Always confer with your physician about Buprenorphine Dosing Interval - 5 conditions. Clinical Trials Search.org is a website devoted to listing clinical research studies in human subjects. Buprenorphine Dosing Interval - 5 Clinical research trials and Buprenorphine Dosing Interval - 5 medical trials take place in hundreds of localities across the U.S.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials usually evaluate the effectualness of new does drugs. The purpose of the studies / projects is to solve specific human health questions. Clinical trials are a popular way for physicians, government agencies, and private sector companies to discover treatments for all sorts of conditions, such as Buprenorphine Dosing Interval - 5. Buprenorphine Dosing Interval - 5 Clinical Trials and other clinical trials permit volunteers to access healthcare treatment choices before they are available to the general public. Some times the subjects recieve professional assistance for without cost, and every now and again they are compensated for their time. Sometimes there is a cost for a Buprenorphine Dosing Interval - 5 clinical trial. Subjects often receive the most expert healthcare possible for their Buprenorphine Dosing Interval - 5 condition. Risks are a reality, nevertheless, and could include additional or frequent dr. calls, healthcare dangers (perhaps life-jeopardising), and/or the treatment being ineffective. Trials are federally governed with stern guidelines to protect clinical trials subjects.

Home > "B" Clinical Trials Conditions > Buprenorphine Dosing Interval - 5

Buprenorphine Dosing Interval - 5



Buprenorphine Dosing Interval - 5

For Condition: Opioid-Related Disorders
Status: Completed
Sponsor(s): National Institute on Drug Abuse (NIDA) ,
Synopsis: Explore feasibility of extending the dosing interval of well maintained buprenorphine patients to 48 and 72 hours, leading to eventual 3 times/week dosing.
Details:
Eligibility:
Study Type:
  Interventional, Treatment, Single Blind, Placebo Control
Minimum Age/Maximum Age: 21 Years/50 Years
Genders: Both
Protocol Entry Criteria: Inclusion Criteria: M/F ages 21-50. Opiate dependence according to DSM-IV critera. Self-reported use within the last 30 days. Agreeable to conditions of study and signed informed consent. Exclusion Criteria: Psychiatric disorder that requires medication therapy. History of seizures. Pregnant and/or nursing women. Dependence on ETOH or benzodiazepines or other sedative-hynotics. Acute hepatitis. Other medical conditions that deem participation to be unsafe.
Total Enrollment: 0

Location and Contact Information:

Overall Study Official:
WalterLing,  Principal Investigator,  Friends Research Institute

Friends Research Institute
Los Angeles,  California,  90025
United States
 


Additional Information:
Study ID Numbers:
  NIDA-06082-5; 
Study Start Date: November 1992
Record last reviewed: September 1994
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00000209

Other Opioid-Related Disorders Studies:
1. Buprenorphine Detox with Two Types of Treatment. BBD II - 11

2. Alternate-Day Buprenorphine Administration. Phase VI - 7

3. Buprenorphine/Naloxone Treatment for Opiod Dependence-Experiment II-2 - 5

4. Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment 1(1) - 1

5. A Laboratory Model for Heroin Abuse Medications - 8

Related Studies:

Other Opioid-Related Disorders Clinical Trials
Other California Clinical Trials
Other Los Angeles Clinical Trials

Buprenorphine Dosing Interval - 5

Modify your Search

  Other Opioid-Related Disorders Clinical Trials
  Other California Clinical Trials
  Other Los Angeles Clinical Trials


Warning: include(/var/www/cgi-bin/traxis/counter.php) [function.include]: failed to open stream: No such file or directory in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103

Warning: include() [function.include]: Failed opening '/var/www/cgi-bin/traxis/counter.php' for inclusion (include_path='.:/usr/local/lib/php') in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103